i-manager Publications

Integrating Wearable Biosensors in Preventive Pharmacology: A New Horizon in Patient Monitoring

Rehan Haider*, Zameer Ahmed**, Sambreen Zameer***

* Department of Pharmacy, University of Karachi, Pakistan.

**-*** Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan.

Periodicity:January - June'2025

Abstract

Preventive pharmacotherapy emphasizes the identification and reduction of illness risks prior to the onset of symptoms. The recent development of wearable biosensors has changed the technique by allowing constant, painless monitoring of biochemical and physiological parameters. This paper explores the integration of wearable biosensors into preventive pharmacology and their transformative potential for patient monitoring. Early detection of drug-related side effects, real-time monitoring of therapeutic effectiveness, and personalized dosage adjustments are among its key applications. The review emphasizes how artificial intelligence (AI), nanotechnology, and digital health ecosystems enable data-driven decision-making and precision pharmacology. Ethical concerns and implementation challenges are also discussed, along with future research directions for integrating biosensors into predictive healthcare systems.

Keywords

Wearable Biosensors, Preventive Pharmacology, Patient Monitoring, Artificial Intelligence, Personalized Medicine.

How to Cite this Article?

Haider, R., Ahmed, Z., and Zameer, S. (2025). Integrating Wearable Biosensors in Preventive Pharmacology: A New Horizon in Patient Monitoring. Dale View's Journal of Clinical Pharmacology and Pharmacotherapeutics, 2(1), 6-10.

References

[1]. Bashir, S., Ahanger, A. N., Assad, A., Bhat, M. R., & Macha, M. A. (2025). Artificial Intelligence in Cardiovascular Diseases. In Artificial Intelligence in Human Health and Diseases (pp. 171-203). Singapore: Springer Nature Singapore.

[2]. Chen, Y. M., Hsiao, T. H., Lin, C. H., & Fann, Y. C. (2025). Unlocking precision medicine: clinical applications of integrating health records, genetics, and immunology through Artificial Intelligence. Journal of Biomedical Science, 32(1), 16.

[3]. Gupta, A., Srivastava, S., Golmei, P., Yadav, L., & Kumar, S. (2025). Signal Amplification to Improve Electrochemical Biosensing for Infectious Diseases. Biotechnology and Applied Biochemistry.

[4]. Hameed, F., & Hameed, K. (2023). The Role of Digital Transformation in Healthcare: A Sustainability Perspective, Design and Integration Challenges, Security and Privacy Challenges, Blockchain Technology, Applications, Future Research Directions.

[5]. Hanafi, M. O., Adediran, G. A., Akinfemisoye, I., Tafirenyika, S., Bello, O., & Chikezie, C. N. (2025). A Review of AI-Wearable Technologies for Public Health Surveillance in the US: Challenges and Recommendations. Journal of Medical Science, Biology, and Chemistry, 2(2), 37-49.

[6]. Khalid, R., Mahmood, S., Mohamed Sofian, Z., Hilles, A. R., Hashim, N. M., & Ge, Y. (2023). Microneedles and their application in t ransdermal deliver y of antihypertensive drugs-a review. Pharmaceutics, 15(8), 2029.

[7]. Kher, R. K., & Patel, D. M. (2021). A comprehensive review on wearable health monitoring systems. The Open Biomedical Engineering Journal, 15(1).

[8]. Koo, K. M., Kim, C. D., Ju, F. N., Kim, H., Kim, C. H., & Kim, T. H. (2022). Recent advances in electrochemical biosensors for monitoring animal cell function and viability. Biosensors, 12(12), 1162.

[9]. Liu, G., Liu, J., Zhou, H., & Wang, H. (2023). Recent advances in nanotechnology-enhanced biosensors for α-fetoprotein detection. Microchimica Acta, 190(1), 3.

[10]. Park, H., & Park, K. (1996). Biocompatibility issues of implantable drug delivery systems. Pharmaceutical Research, 13(12), 1770-1776.

[11]. Patel, D. D., Pathak, R. S., Patel, K. S., Bhatt, H. G., & Patel, P. K. (2025). The Future of Medicine: AI and ML Driven Drug Discovery Advancements. Current Topics in Medicinal Chemistry.

[12]. Song, Y., Hu, C., Wang, Z., & Wang, L. (2024). Silk-based wearable devices for health monitoring and medical treatment. iScience, 27(5), 109604.

[13]. Spuskanyuk, A. (2024). Ethical implications of wearable digital health technology: Balancing innovation and patient autonomy. American Journal of Health and Community Sciences, 1(2).

[14]. World Health Organization. (2023). Regulatory Considerations on Artificial Intelligence for Health. World Health Organization.

[15]. Yunlong, B., Xu, T., & Zhang, X. (2020). Graphene-based biosensors for detection of biomarkers. Micromachines, 11, 60.

[16]. Zhong, J., Mareque-Rivas, J. C., Lan, X., & Su, Y. X. (2025). Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives. Aggregate, e70081.

If you have access to this article please login to view the article or kindly login to purchase the article

Single Article

	North Americas,UK, Middle East,Europe		India	Rest of world
	USD	EUR	INR	USD-ROW
Pdf	300
Online	300
Pdf & Online	500

ADD TO CART

Options for accessing this content:

If you would like institutional access to this content, please recommend the title to your librarian.
If you already have i-manager's user account: Login above and proceed to purchase the article.
New Users: Please register, then proceed to purchase the article.